Language: BG BG
← Back to results
Not yet recruiting Not applicable NCT06909500

A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

No applicable phase (e.g. observational)
Conditions: Nicotine Dependence Tobacco-Related Carcinoma

Sponsor: Fred Hutchinson Cancer Center

trial.available_in: БГ
Overview
This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.
Description
OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use the ACT on Vaping app (Version A) and receive a text messaging program to motivate and support quitting. Participants also receive incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess their vaping status. ARM II: Participants use the ACT on Vaping app (Version B) and receive incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess their vaping status. After completion of study intervention, participants are followed up at 3 and 6 months.
Who can participate
Inclusion Criteria: * Age 18-30 * Age of majority (to provide informed consent) in current state/territory of residence * Current weekly user of e-cigarette product(s) for the last 30 days * Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent) * Experience downloading and using one or more apps on their smartphone * Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app * Has access to text messaging * Has an email address * United States (US) resident, with a US mailing address * Willing to complete all study procedures * Comfortable reading and writing in English Exclusion Criteria: * Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation) * Member of the same household as another research participant * Currently in prison * Google voice number as sole phone number, due to its association with fraudulent study entry attempts * Is ineligible per fraud prevention protocol * Employees/family of investigator or study center
Interventions
Smartphone app
BEHAVIORAL
Smartphone app
BEHAVIORAL
Text Message
OTHER
Text Message
OTHER
Survey Administration
OTHER
Locations 1
United States (1)
Fred Hutch/University of Washington Cancer Consortium
Seattle , Washington
Technical details
Status
Not yet recruiting
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Maximum age
30 Years
Healthy volunteers
No
Start date
30.04.2026
Completion date
15.11.2027
Registry ID
NCT06909500
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.